AventaMed

Cork, Ireland Founded: 2013 • Age: 13 yrs Acquired By Karl Storz
Device for safe placement of grommets
Request Access

About AventaMed

AventaMed is a company based in Cork (Ireland) founded in 2013 by Keith Jansen, John Vaughan, and Olive Odriscoll was acquired by Karl Storz in February 2023.. AventaMed has raised $3.58 million across 4 funding rounds from investors including Enterprise Ireland, Karl Storz and HBAN. AventaMed offers products and services including Solo+ ™. AventaMed operates in a competitive market with competitors including Preceptis Medical, NousQ, Tympanogen, Doya Medical and EntraTympanic, among others.

  • Headquarter Cork, Ireland
  • Founders Keith Jansen, John Vaughan, Olive Odriscoll
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aventamed Dac
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.58 M (USD)

    in 4 rounds

  • Latest Funding Round
    $2.12 M (USD), Angel Round

    Oct 20, 2017

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Karl Storz

    (Feb 08, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AventaMed

AventaMed offers a comprehensive portfolio of products and services, including Solo+ ™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for quick ear tube insertion using topical anesthesia.

People of AventaMed
Headcount 1-10
Employee Profiles 2
Board Members and Advisors 6
Employee Profiles
People
John Vaughan
CTO, Director & Co-Founder
People
Keith Jansen
President & CEO

Unlock access to complete

Board Members and Advisors
people
Rick Geoffrion
Chairman & Non-Executive Director
people
Bernard Lim
Non-Executive Director
people
Bruce Clibborn
Board Member
people
Jack Cashman
Non-Executive Director

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of AventaMed

AventaMed has successfully raised a total of $3.58M across 4 strategic funding rounds. The most recent funding activity was a Angel Round round of $2.12 million completed in October 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Angel Round — $2.1M
  • First Round

    (24 Nov 2014)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2017 Amount Angel Round - AventaMed Valuation Halo Business Angel Network
Oct, 2015 Amount Grant - AventaMed Valuation

investors

Sep, 2015 Amount Seed - AventaMed Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AventaMed

AventaMed has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, Karl Storz and HBAN. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
A platform connecting angel investors to startups in Ireland.
Founded Year Domain Location
-
Founded Year Domain Location
Support is provided to Irish manufacturing and service sector businesses.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AventaMed

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AventaMed

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aventamed Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AventaMed

AventaMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Preceptis Medical, NousQ, Tympanogen, Doya Medical and EntraTympanic, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Surgical tools for pediatric ear tube procedures are developed.
domain founded_year HQ Location
Developer of a robotic surgical applicator for ear tube surgery. This device aims to simplify the procedure, reducing the need for general anesthesia and a surgical microscope. It enables outpatient settings and potentially reduces costs. The applicator uses commercially available ear tubes and features safety and precision enhancements through robotics and sensor technology. It makes a precise incision on the eardrum, improving outcomes for patients.
domain founded_year HQ Location
Provider of gel patch for chronic tympanic membrane perforations
domain founded_year HQ Location
Develops non-invasive stent technology for treating otitis media with effusion.
domain founded_year HQ Location
Medical device for the treatment of middle ear infections
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aventamed

Frequently Asked Questions about AventaMed

When was AventaMed founded?

AventaMed was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is AventaMed located?

AventaMed is headquartered in Cork, Ireland.

Who is the current CEO of AventaMed?

Keith Jansen is the current CEO of AventaMed. They have also founded this company.

Is AventaMed a funded company?

AventaMed is a funded company, having raised a total of $3.58M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.46M, raised on Nov 24, 2014.

What does AventaMed do?

AventaMed is developing surgical devices, initially focused on a device which allows safe placement of ear tubes or grommets in an out-patient setting. Grommets are used to surgically treat Otitis Media with Effusion, which is a build up of fluid behind the ear drum. Was spun out from the MEDIC research centre, Cork Institute of Technology.

Who are the top competitors of AventaMed?

AventaMed's top competitors include Preceptis Medical, Tympanogen and NousQ.

What products or services does AventaMed offer?

AventaMed offers Solo+ ™.

Who are AventaMed's investors?

AventaMed has 4 investors. Key investors include Enterprise Ireland, Karl Storz, HBAN, and Irrus Investments.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available